---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-004667"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2024-07-03T23:59:59+00:00"
generated_at: "2026-05-31T23:32:02.452463+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CNS Pharmaceuticals announces $1.98M registered direct offering and private placement

## Summary
- Sold 1,425,000 shares at $1.39 per share with common warrants at $1.26 exercise price.
- Gross proceeds ~$1.98M; net proceeds for working capital and general corporate purposes.
- Closing expected July 5, 2024; warrants expire 5 years from issuance.
- A.G.P./Alliance Global Partners acting as financial advisor with 6.5% fee.

## SEC filing metadata
- accession: 0001683168-24-004667
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2024-07-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316824004667/0001683168-24-004667-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316824004667/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-004667
- JSON: https://secwatch.observer/filing/0001683168-24-004667.json
- Plain text: https://secwatch.observer/filing/0001683168-24-004667.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.